Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease (Q43540752)

24 November 2017

Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease (English)

1 reference

24 November 2017

1 reference

Hurley MJ

1

1 reference

PubMed ID

11245931

24 November 2017

Mash DC

series ordinal

2

1 reference

PubMed ID

11245931

24 November 2017

Jenner P

series ordinal

3

1 reference

24 November 2017

1 March 2001

1 reference

24 November 2017

Molecular Brain Research

1 reference

24 November 2017

87

1 reference

24 November 2017

271-279

1 reference

24 November 2017

2

1 reference

Basic local alignment search tool

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

What do the basal ganglia do?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Selective full dopamine D1-like (SKF-82958) and D2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Biochemical aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Apomorphine and dopamine D(1) receptor agonists increase the firing rates of subthalamic nucleus neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Mapping of D1 dopamine receptor mRNA by non-radioactive in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Parkinson's disease: low density and presynaptic location of D3 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

1 reference

7 January 2021

Visualization of a dopamine D1 receptor mRNA in human and rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Treatment of Parkinson's disease should begin with a dopamine agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

1 reference

7 January 2021

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Dopamine D-1 receptors in the parkinsonian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Getting the message from the gene to the synapse: sorting and intracellular transport of RNA in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-ioduced parkinsonism in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

D1 and D2 dopamine receptor mRNA in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

Pharmacological and molecular evidence for dopamine D1 receptor expression by striatal astrocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2801%2900022-5

7 January 2021

10.1016/S0169-328X(01)00022-5

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11245931